Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > Partnering > Partnering Highlights > Partnering Highlights

Partnering Highlights

Partnering Highlights

When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.

Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships

Recent Partnerships

Pages

  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
March 12, 2012 Biocon And Pfizer Conclude Commercialization Agreement
February 27, 2012 Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company
February 17, 2012 Pfizer And Hisun Announce Progress On Potential Joint Venture
January 25, 2012 KineMed announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.
January 10, 2012 Ventana Medical Systems announced a collaboration with Pfizer on a companion diagnostic to identify lung cancer patients with ALK gene rearrangements.
January 9, 2012 SFJ Pharma announced a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma(RCC) following nephrectomy.
Printable Version
 
 

Submit Your Opportunity

callout-placeholder

Send us your innovative ideas today.

  • Get started now

Source URL: http://www.pfizer.com/partnering/partnership_highlights/news/press_releases/news/press_releases/news/press_releases/pfizer_press_release?page=3